Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ross

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Scleroderma and Related Disorders|May 26, 2025
Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort StudyJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of Patient Experience|July 23, 2025
Impact of COVID-19 Pandemic on the Management of Oncology Patients in Eastern CanadaMahmoud Abdelsalam, Laura Ross, Rana Sughayar, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
The Lancet. Global Health|March 28, 2025
Reporting summary results in clinical trial registries: updated guidance from WHOAn-Wen Chan, Ghassan Karam, Justin Pymento, et al.
Arthritis Research & Therapy|April 12, 2022
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosisLaura Ross, Anniina Lindqvist, Benedict Costello, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability IndexJessica L Fairley, Dylan Hansen, Murray Baron, et al.
Clinical and Experimental Rheumatology|August 17, 2024
The burden and determinants of fatigue in incident and prevalent systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Research & Therapy|February 16, 2019
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosisJayne Moxey, Molla Huq, Susanna Proudman, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Clinical Rheumatology|November 3, 2023
The effect of calcium channel blockers on digital ulcers in systemic sclerosis: data from a prospective cohort studyLaura Ross, Dylan Hansen, Nancy Maltez, et al.
Journal of Scleroderma and Related Disorders|May 26, 2025
Frequency and determinants of use of immunosuppressants in the Australian Scleroderma Cohort StudyJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of Patient Experience|July 23, 2025
Impact of COVID-19 Pandemic on the Management of Oncology Patients in Eastern CanadaMahmoud Abdelsalam, Laura Ross, Rana Sughayar, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
The Lancet. Global Health|March 28, 2025
Reporting summary results in clinical trial registries: updated guidance from WHOAn-Wen Chan, Ghassan Karam, Justin Pymento, et al.
Arthritis Research & Therapy|April 12, 2022
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosisLaura Ross, Anniina Lindqvist, Benedict Costello, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability IndexJessica L Fairley, Dylan Hansen, Murray Baron, et al.
Clinical and Experimental Rheumatology|August 17, 2024
The burden and determinants of fatigue in incident and prevalent systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Arthritis Research & Therapy|February 16, 2019
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosisJayne Moxey, Molla Huq, Susanna Proudman, et al.
Pageof 18